Endocrine Risk Factors for Cognitive Impairment

Area of Science:

• Gerontology
• Endocrinology
• Neuroscience

Background:

• Cognitive impairment, including Alzheimer's disease, is a significant global health issue in aging populations.
• Current treatments for cognitive impairment lack efficacy, highlighting the need to explore modifiable risk factors.
• Metabolic and endocrine factors are increasingly recognized as crucial in cognitive impairment's pathogenesis.

Purpose of the Study:

• To review epidemiological evidence linking endocrine risk factors to cognitive impairment.
• To explore potential molecular mechanisms underlying these associations.
• To assess the therapeutic potential of modifying these endocrine risk factors.

Main Methods:

• Systematic review of epidemiological studies on endocrine risk factors and cognitive impairment.
• Analysis of research on molecular pathways connecting endocrine dysfunction to cognitive decline.
• Evaluation of findings from interventional studies targeting modifiable endocrine risk factors.

Main Results:

• Strong epidemiological associations exist between cognitive impairment and insulin resistance, dyslipidemia, thyroid dysfunction, vitamin D deficiency, and subclinical atherosclerosis.
• Several plausible biological mechanisms link these endocrine factors to neurodegeneration and cognitive deficits.
• Interventional studies aiming to modify these risk factors have yielded inconsistent results regarding cognitive benefits.

Conclusions:

• Endocrine risk factors represent promising targets for understanding and potentially preventing cognitive impairment.
• The variable outcomes of current interventions underscore the need for rigorous, large-scale, randomized controlled trials.
• Further research is essential to establish effective strategies for mitigating endocrine-related cognitive decline.